Pro Share Advisors LLC Atai Life Sciences N.V. Transaction History

Pro Share Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.27 - $2.6 $1,653 - $3,385	-1,302 Reduced 11.19%	10,333 $13,000
Q1 2024 May 08, 2024	BUY	$1.5 - $2.19 $1,542 - $2,251	1,028 Added 9.69%	11,635 $22,000
Q4 2023 Feb 14, 2024	SELL	$1.04 - $1.55 $255 - $381	-246 Reduced 2.27%	10,607 $14,000
Q3 2023 Nov 13, 2023	BUY	$1.27 - $2.28 $140 - $253	111 Added 1.03%	10,853 $14,000
Q2 2023 Aug 10, 2023	SELL	$1.44 - $2.19 $1,091 - $1,660	-758 Reduced 6.59%	10,742 $18,000
Q1 2023 May 25, 2023	BUY	$1.17 - $2.7 $13,455 - $31,050	11,500 New	11,500 $20,000
Q4 2022 Feb 02, 2023	BUY	$2.38 - $3.55 $257 - $383	108 Added 0.79%	13,719 $36,000
Q3 2022 Nov 04, 2022	BUY	$3.14 - $4.87 $3,435 - $5,327	1,094 Added 8.74%	13,611 $45,000
Q2 2022 Aug 01, 2022	SELL	$3.03 - $5.32 $12,338 - $21,663	-4,072 Reduced 24.55%	12,517 $46,000
Q1 2022 May 10, 2022	SELL	$4.66 - $7.66 $27,885 - $45,837	-5,984 Reduced 26.51%	16,589 $84,000
Q4 2021 Feb 08, 2022	BUY	$6.82 - $17.8 $153,947 - $401,799	22,573 New	22,573 $172,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.